61 completed, 24 unknown, 13 terminated, 11 recruiting. 52 Phase 2, 20 Phase 1, 14 Not applicable, 12 Phase 3, 1 Phase 4.
Follow Gallbladder Cancer: new trials by email Literature Review of Gallbladder Cancer trials Research Report on Gallbladder Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hepatic Arterial Infusion Chemotherapy Versus Capecitabine as Adjuvant Therapy for Resected Biliary Tract Cancer Oxaliplatin, 5-Fluorouracil, Capecitabine - Biliary Tract Cancer, Cholangiocarcinoma | Phase 3 | Not yet recruiting | Zhai Wenlong | 90 | 2026-11-30 | 2026-11-04 |
| AK112 Combined With GAP Conversion Therapy for Locally Advanced Gallbladder Cancer AK112, Gemcitabine, Cisplatin - Gallbladder Cancer | Phase 2 | Not yet recruiting | First Affiliated Hospital Xi'an Jiaotong University | 22 | 2026-08-28 | 2026-08-17 |
| Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer BTC-Ag-T (ACH-AgT001), Cyclophosphamide and Fludarabine - Biliary Tract Neoplasms, Cholangiocarcinoma, Intrahepatic | Phase 1 | Recruiting | Shanghai Zhongshan Hospital | 18 | 2026-05-01 | 2026-05-29 |
| Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer Trifluridine/tipiracil, Oxaliplatin - Biliary Tract Cancer, Biliary Tract Neoplasms | Phase 2 | Suspended | Case Comprehensive Cancer Center | 27 | 2025-12-01 | 2026-10-20 |
| Proteomic Analysis of Patients Undergoing Bariatric Surgery bariatric surgery - Obesity, Colon Cancer | Not applicable | Not yet recruiting | Universidade Federal de Pernambuco | 103 | 2025-06-10 | 2025-01-22 |
| Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer Capecitabine, Toripalimab - Gallbladder Cancer, Hilar Cholangiocarcinoma | Phase 2 | Active not recruiting | Tianjin Medical University Cancer Institute and Hospital | 110 | 2024-11-12 | 2024-12-05 |
| Predicting Incidental Gallbladder Cancer Gallbladder Cancer | Active not recruiting | University Hospital Plymouth NHS Trust | 30000 | 2024-10-02 | 2026-09-17 | |
| Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors MDX2001 - Biliary Tract Cancer, Breast Cancer | Phase 1 / Phase 2 | Recruiting | ModeX Therapeutics, An OPKO Health Company | 330 | 2024-06-12 | 2026-10-15 |
| Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT) Gemcitabine nab-PaclitaxelLenvatinibTislelizumab - Gallbladder Cancer, Cholangiocarcinoma | Phase 2 | Enrolling by invitation | Wei Gong | 44 | 2024-06-01 | 2025-05-08 |
| Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer no interventions - Biliary Tract Diseases, Gallbladder Cancer | Not yet recruiting | RenJi Hospital | 5000 | 2024-03-01 | 2024-02-28 | |
| STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy single transversus abdominis laparoscopy-guided plane block, local trocar site ropivacaine infiltration - Cholelithiasis, Cholecystitis | Not applicable | Recruiting | Helsinki University Central Hospital | 850 | 2024-01-16 | 2026-10-05 |
| UCAD for Diagnosing Benign or Malignant Gallbladder Diseases and Follow-up The level of CNV - Gallbladder Cancer | Unknown | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 1 | 2024-01-01 | 2024-02-01 | |
| Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer HAIC, Surufatinib, Tislelizumab - Carcinoma, Intrahepatic Cholangiocarcinoma | Phase 2 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 41 | 2023-11-01 | 2023-11-18 |
| Global Evaluation of Cholecystectomy Knowledge and Outcomes Gallstone, Gallbladder Cancer | Completed | University of Edinburgh | 53708 | 2023-07-31 | 2025-03-14 | |
| The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases no interventions - Biliary Tract Diseases, Gallbladder Cancer | Not yet recruiting | RenJi Hospital | 500 | 2023-07-01 | 2023-06-09 | |
| A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors certepetide, Durvalumab, Cisplatin - Cholangiocarcinoma, Gallbladder Cancer | Phase 2 | Completed | Lisata Therapeutics, Inc. | 66 | 2023-05-13 | 2026-09-28 |
| Robot-assisted vs Laparoscopic vs Open Radical Cholecystectomy for Gallbladder Cancer Minimally invasive surgery - Gallbladder Cancer | Unknown | Hospital del Mar | 600 | 2023-04-01 | 2023-09-29 | |
| Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC Envafolimab+Gemox - Gallbladder Cancer | Phase 2 | Unknown | Eastern Hepatobiliary Surgery Hospital | 30 | 2023-03-17 | 2023-09-15 |
| Deep Learning Radiogenomics For Individualized Therapy in Unresectable Gallbladder Cancer CT scan - Gallbladder Cancer | Unknown | Post Graduate Institute of Medical Education and Research, Chandigarh | 75 | 2023-02-15 | 2023-02-08 | |
| Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer Combination of Gemcitabine, Nab-paclitaxel, Sintilimab and Bevacizumab - Gallbladder Cancer, Initially Unresectable | Phase 2 | Recruiting | Lu Wang, MD, PhD | 50 | 2022-12-22 | 2023-03-07 |
Showing 20 of 122. Sign in to see all of them.
Gallbladder Neoplasms (122) · Bile Duct Neoplasms (49) · Pancreatic Neoplasms (39) · Cholangiocarcinoma (38) · Liver Neoplasms (36) · Biliary Tract Neoplasms (29) · Stomach Neoplasms (27) · Carcinoma, Hepatocellular (22) · Colonic Neoplasms (17) · Colorectal Neoplasms (17) · Esophageal Neoplasms (17) · Rectal Neoplasms (14) · Anus Neoplasms (10) · Breast Neoplasms (10) · Lung Neoplasms (9)
Digestive System Diseases (122) · Digestive System Neoplasms (122) · Gallbladder Diseases (122) · Neoplasms by Site (122) · Biliary Tract Diseases (120) · Neoplasms (116) · Biliary Tract Neoplasms (93) · Neoplasms by Histologic Type (67) · Neoplasms, Glandular and Epithelial (64) · Adenocarcinoma (62) · Carcinoma (59) · Bile Duct Diseases (49) · Endocrine Gland Neoplasms (41) · Endocrine System Diseases (41) · Liver Diseases (40)
Gemcitabine (27) · Oxaliplatin (12) · Cisplatin (11) · Capecitabine (10) · Fluorouracil (8) · Leucovorin (5) · 130-nm albumin-bound paclitaxel (4) · Erlotinib Hydrochloride (4) · Radiotherapy (4) · Immunohistochemistry (3) · Irinotecan (3) · Sorafenib (3) · Bevacizumab (2) · Carboplatin (2) · Chemotherapy, Adjuvant (2)
Memorial Sloan Kettering Cancer Center (5) · Alliance for Clinical Trials in Oncology (4) · Shanghai Jiao Tong University School of Medicine (3) · All India Institute of Medical Sciences (2) · Banaras Hindu University (2) · Case Comprehensive Cancer Center (2) · City of Hope Medical Center (2) · EMD Serono Research & Development Institute, Inc. (2) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (2) · Mayo Clinic (2) · National Cancer Institute (NCI) (2) · RenJi Hospital (2) · SWOG Cancer Research Network (2) · Samsung Medical Center (2) · The Christie NHS Foundation Trust (2)
United States (53) · China (21) · South Korea (12) · United Kingdom (11) · France (7) · Germany (6) · India (6) · Spain (5) · Canada (4) · Italy (4) · Argentina (3) · Australia (3) · Chile (3) · Denmark (3) · Japan (3)
Steven R. Alberts, MD (3) · Benjamin Tan, M.D. (2) · Herbert K. Lyerly, MD (2) · Afshin Dowlati, MD (1) · Aram Hezel, MD (1) · Ari D Baron, MD (1) · Arndt Vogel, Prof. (1) · Arndt Vogel, Prof. Dr. (1) · Bert H. O'Neil, MD (1) · Bert Hildebrandt, MD (1) · Bo Ohlin, M.D. (1) · Brennan Spiegel, MD, MSHS (1) · Bruno Chauffert (1)
PMID 32461347, PMID 11261621, PMID 12196376, PMID 12455783, PMID 12794246, PMID 12850683, PMID 15558814, PMID 16875082, PMID 18669454, PMID 18669455, PMID 19023677, PMID 19399502, PMID 20375404, PMID 20662793, PMID 21034892, PMID 21556747, PMID 25241229, PMID 25538178, PMID 25964250, PMID 30473706, PMID 33210382, PMID 33798493, PMID 34545545, PMID 35274717, PMID 36018415, PMID 36154291, PMID 36879265, PMID 36999533, PMID 38087967, PMID 38661512, PMID 38704628, PMID 38865181, PMID 38875119, PMID 39059804, PMID 40638104, PMID 41428976, PMID 41495607, PMID 41519150, PMID 41887529
P30CA015083 (2), P30CA068485 (2), U10CA032102 (2), 2015 (1), 2018 (1), 2019 (1), 2023 (1), K01AT008219 (1), K07CA118576 (1), K23CA115908 (1), P30CA008748 (1), P30CA016086 (1), P30CA016672 (1), P30CA033572 (1), P30CA036727 (1)